Hygeia Healthcare Holdings Co., Limited (HKG:6078)
Hong Kong
· Delayed Price · Currency is HKD 14.86
+0.02 (0.13%)
May 14, 2025, 4:08 PM HKT
HKG:6078 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 4,446 | 4,077 | 3,196 | 2,315 | 1,402 | Upgrade
|
| Revenue Growth (YoY) | 9.06% | 27.57% | 38.02% | 65.17% | 29.10% | Upgrade
|
| Cost of Revenue | 3,141 | 2,810 | 2,179 | 1,571 | 929.81 | Upgrade
|
| Gross Profit | 1,305 | 1,267 | 1,017 | 744.66 | 471.96 | Upgrade
|
| Selling, General & Admin | 424.94 | 413.34 | 292.95 | 225.42 | 152.43 | Upgrade
|
| Other Operating Expenses | 4.01 | -13.74 | -11.65 | -6.37 | 1.39 | Upgrade
|
| Operating Expenses | 486.57 | 399.6 | 281.3 | 219.05 | 153.83 | Upgrade
|
| Operating Income | 818.54 | 867.28 | 735.77 | 525.61 | 318.13 | Upgrade
|
| Interest Expense | -71.84 | -43.17 | -34.88 | -23.09 | -48.17 | Upgrade
|
| Interest & Investment Income | 1.51 | 10.15 | 17.32 | 2.16 | 0.5 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.07 | 0.44 | 9.81 | -1.32 | Upgrade
|
| EBT Excluding Unusual Items | 748.21 | 834.19 | 718.65 | 514.49 | 269.14 | Upgrade
|
| Gain (Loss) on Sale of Investments | 10.52 | 15.56 | 2.39 | 46.28 | 43.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | -6.51 | -4.83 | -0.45 | -3.37 | -1.78 | Upgrade
|
| Other Unusual Items | -1.4 | 11.17 | -77.27 | 15.45 | -57.85 | Upgrade
|
| Pretax Income | 750.82 | 856.09 | 643.31 | 572.85 | 252.61 | Upgrade
|
| Income Tax Expense | 152.48 | 171.14 | 161.44 | 119.64 | 75.55 | Upgrade
|
| Earnings From Continuing Operations | 598.33 | 684.95 | 481.88 | 453.2 | 177.06 | Upgrade
|
| Minority Interest in Earnings | -0.07 | -2.02 | -5.09 | -11.75 | -6.98 | Upgrade
|
| Net Income | 598.26 | 682.93 | 476.78 | 441.46 | 170.09 | Upgrade
|
| Net Income to Common | 598.26 | 682.93 | 476.78 | 441.46 | 170.09 | Upgrade
|
| Net Income Growth | -12.40% | 43.24% | 8.00% | 159.55% | 327.70% | Upgrade
|
| Shares Outstanding (Basic) | 629 | 631 | 617 | 618 | 447 | Upgrade
|
| Shares Outstanding (Diluted) | 629 | 631 | 617 | 618 | 449 | Upgrade
|
| Shares Change (YoY) | -0.34% | 2.32% | -0.19% | 37.50% | 60.20% | Upgrade
|
| EPS (Basic) | 0.95 | 1.08 | 0.77 | 0.71 | 0.38 | Upgrade
|
| EPS (Diluted) | 0.95 | 1.08 | 0.77 | 0.71 | 0.38 | Upgrade
|
| EPS Growth | -12.04% | 40.26% | 8.45% | 86.84% | 175.44% | Upgrade
|
| Free Cash Flow | 109.55 | -142.84 | 92.26 | -236.84 | -25.77 | Upgrade
|
| Free Cash Flow Per Share | 0.17 | -0.23 | 0.15 | -0.38 | -0.06 | Upgrade
|
| Dividend Per Share | - | - | 0.150 | - | 0.120 | Upgrade
|
| Gross Margin | 29.35% | 31.08% | 31.83% | 32.16% | 33.67% | Upgrade
|
| Operating Margin | 18.41% | 21.27% | 23.02% | 22.70% | 22.70% | Upgrade
|
| Profit Margin | 13.46% | 16.75% | 14.92% | 19.07% | 12.13% | Upgrade
|
| Free Cash Flow Margin | 2.46% | -3.50% | 2.89% | -10.23% | -1.84% | Upgrade
|
| EBITDA | 1,079 | 1,048 | 868.43 | 623.67 | 385.36 | Upgrade
|
| EBITDA Margin | 24.27% | 25.70% | 27.18% | 26.94% | 27.49% | Upgrade
|
| D&A For EBITDA | 260.36 | 180.56 | 132.66 | 98.06 | 67.23 | Upgrade
|
| EBIT | 818.54 | 867.28 | 735.77 | 525.61 | 318.13 | Upgrade
|
| EBIT Margin | 18.41% | 21.27% | 23.02% | 22.70% | 22.70% | Upgrade
|
| Effective Tax Rate | 20.31% | 19.99% | 25.09% | 20.89% | 29.91% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.